Cystatin C and chronic kidney disease in children

S.V. Kushnirenko, Ye.M. Mordovets, N.A. Tihonenko, O.O. Markotenko


Background. Determination of diagnostically significant values of serum concentration of cystatin C in combination with the estimated glomerular filtration rate (GFR) gives clinicians an advantage in clearly differentiation of chronic kidney disease stages in children and understanding the need for wider use of one of the most important diagnostic tests in the practice of a pediatric nephrologist and pediatrician. The aim of the study was to determine the diagnostic values of the serum concentration of cystatin C with the calculated glomerular filtration rate for the differentiation of the stage І–ІІІ chronic kidney disease. Materials and methods. In 119 children aged 2 to 17 years (7.3 ± 0.3 years), diagnostically significant values of serum cystatin C were determined to distinguish stage І–ІІІ chronic kidney disease, glomerular filtration rate was calculated based on the serum concentration of cystatin C using the equations of F.J. Hoek, M. Zappitelli, Pediatric GFR Calculator — The National Kidney Foundation (NKF). Results. In children with stage I chronic kidney disease, serum concentration of cystatin C was 0.77 ± 0.01 mg/l, which is significantly lower than the corresponding values in patients with chronic kidney disease stage ІІ (1.00 ± 0.01 mg/l) and stage ІІІ (1.58 ± 0.06 mg/l) (p < 0.05). The mean value of the concentration of cystatin C in the blood serum (0.77 ± 0.01 mg/l) in patients with stage I chronic kidney disease corresponded to the calculated glomerular filtration rate on the basis of cystatin C: 100.2 ± 1.6 ml/min/1.73 m2 determined according to the equation of F.J. Hoek, 103.6 ± 1.9 ml/min/1.73 m2 — according to the equation of M. Zappitelli and 90.4 ± 1.3 ml/min/1.73 m2 by the Pediatric GFR Calculator — NKF. The average value of cystatin C in the blood serum (1.00 ± 0.01 mg/l) in patients with stage II chronic kidney disease corresponded to the calculated glomerular filtration rate on the basis of cystatin C: 77.50 ± 0.87 ml/min/1.73 m2 according to the equation of F.J. Hoek, 77.60 ± 0.97 ml/min/1.73 m2 according to the equation of M. Zappitelli and 71.9 ± 0.7 ml/min/1.73 m2 by the Pediatric GFR Calculator-NKF. The average values of the estimated glomerular filtration rate based on cystatin C calculated by Pediatric GFR Calculator — NKF significantly differed from the results of the two previous equations (p < 0.05). Values of cystatin C in the blood serum (1.58 ± 0.06 mg/l) obtained in patients with stage III chronic kidney disease corresponded to almost identical estimated glomerular filtration rate on the basis of cystatin C determined from three different equations. Conclusions. The data obtained and the results of several stu­dies confirm that in children, cystatin C better correlates with the glomerular filtration rate than serum creatinine. Diagnostically significant values for the differentiation of stage І–ІІІ chronic kidney disease are determined. The informative value of the equations for calcula­ting the glomerular filtration rate on the basis of cystatin C was evaluated (F.J. Hoek, M. Zappitelli, Pediatric GFR Calculator — NKF).


cystatin C; chronic kidney disease; children


Velkov VV. New Renal Biomarkers for Neonatology and Pediatrics: Cystatin C and NGAL. Journal «Pediatria» named after G.N. Speransky. 2015;14(3):167-74.

Kayukov IG, Smirnov AV, Emanuel VL. Cystatin c in current medicine. Nephrology (Saint-Petersburg). 2012;16(1):22-37.

Allegaert K, Mekahli D, van den Anker J. Cystatin C in newborns: a promising renal biomarker in search for standardization and validation. J Matern Fetal Neonatal Med. 2015;28(15):1833-8. doi: 10.3109/14767058.2014.969236.

Ataei N, Bazargani B, Ameli S, et al. Early detection of acute kidney injury by serum cystatin C in critically ill children. Pediatr Nephrol. 2014 Jan;29(1):133-8. doi: 10.1007/s00467-013-2586-5.

Bansal N, Vittinghoff E, Peralta CA, et al. Estimated kidney function based on serum cystatin C and risk of subsequent coronary artery calcium in young and middle-aged adults with preserved kidney function: results from the CARDIA study. Am J Epidemiol. 2013 Aug 1;178(3):410-7. doi: 10.1093/aje/kws581.

Bökenkamp A, Domanetzki M, Zinck R, Schumann G, Byrd D, Brodehl J. Cystatin C-a new marker of glomerular filtration rate in children independent of age and height. Pediatrics. 1998 May;101(5):875-81. PMID: 9565418.

Bökenkamp A, Domanetzki M, Zinck R, Schumann G, Brodehl J. Reference values for cystatin C serum concentrations in children Pediatr Nephrol. 1998 Feb;12(2):125-9. PMID: 9543370.

Brady TM, Townsend K, Schneider MF, et al. Cystatin C and cardiac measures in children and adolescents with CKD. Am J Kidney Dis. 2017 Feb;69(2):247-256. doi: 10.1053/j.ajkd.2016.08.036.

Codoñer-Franch P, Ballester-Asensio E, Martínez-Pons L, et al. Cystatin C, cardiometabolic risk, and body composition in severely obese children. Pediatr Nephrol. 2011 Feb;26(2):301-7. doi: 10.1007/s00467-010-1679-7.

Dangle PP, Ayyash O, Kang A, et al. Cystatin C-calculated glomerular filtration rate-a marker of early renal dysfunction in patients with neuropathic bladder. Urology. 2017 Feb;100:213-217. doi: 10.1016/j.urology.2016.08.011.

Dharnidharka VR, Kwon C, Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: A meta-analysis. Am J Kidney Dis. 2002 Aug;40(2):221-6. doi: 10.1053/ajkd.2002.34487.

Dönmez O, Korkmaz HA, Yıldız N, Ediz B. Comparison of serum cystatin C and creatinine levels in determining glomerular filtration rate in children with stage I to III chronic renal disease Ren Fail. 2015 Jun;37(5):784-90. doi: 10.3109/0886022X.2015.1014771.

Filler G, Grimmer J, Huang SH, Bariciak E. Cystatin C for the assessment of GFR in neonates with congenital renal anomalies Nephrol Dial Transplant. 2012 Sep;27(9):3382-4. doi: 10.1093/ndt/gfs253.

Filler G, Melk A, Marks SD. Practice recommendations for the monitoring of renal function in pediatric non-renal organ transplant recipients. Pediatr Transplant. 2016 May;20(3):352-63. doi: 10.1111/petr.12685.

Fischbach M, Graff V, Terzic J, Bergère V, Oudet M, Hamel G. Impact of age on reference values for serum concentration of cystatin C in children. Pediatr Nephrol. 2002 Feb;17(2):104-6. PMID: 11875672.

Flynn JT, Daniels SR, Hayman LL, et al. Update: ambulatory blood pressure monitoring in children and adolescents: a scientific statement from the American Heart Association. Hypertension. 2014 May;63(5):1116-35. doi: 10.1161/HYP.0000000000000007.

Fox JA, Dudley AG, Bates C, Cannon GM Jr. Cystatin C as a marker of early renal insufficiency in children with congenital neuropathic bladder. J Urol. 2014 May;191(5 Suppl):1602-7. doi: 10.1016/j.juro.2013.09.093.

Franco MC, Nagasako SS, Machado PG, Nogueira PC, Pestana JO, Sesso R. Cystatin C and renal function in pediatric kidney transplant recipients Braz J Med Biol Res. 2009 Dec;42(12):1225-9. PMID: 19882084.

Harmoinen A, Ylinen E, Ala-Houhala M, Janas M, Kaila M, Kouri T. Reference intervals for cystatin C in pre- and full-term infants and children. Pediatr Nephrol. 2000 Nov;15(1-2):105-8. PMID: 11095024.

Hoek FJ, Kemperman FA, Krediet RT. A comparison between cystatin C, plasma creatinine and the Cockcroft and Gault formula for the estimation of glomerular filtration rate. Nephrol Dial Transplant. 2003 Oct;18(10):2024-31. doi: 10.1093/ndt/gfg349.

Pediatric GFR calculator. Available from:

Kidney Disease: Improving Global Outcomes (KDIGO) СKD Work Group. KDIGO 2012 Clinical Practice Guideline for the for the Evaluation and Management of Chronic Kidney Disease. Kidney International Supplements. 2013;3(1):1-150.

Krawczeski CD, Vandevoorde RG, Kathman T, et al. Serum cystatin C is an early predictive biomarker of acute kidney injury after pediatric cardiopulmonary bypass Clin J Am Soc Nephrol. 2010 Sep;5(9):1552-7. doi: 10.2215/CJN.02040310.

Liu D, Alvarez-Elías AC, Wile B, Belostotsky V, Filler G. Deviations from the expected relationship between serum FGF23 and other markers in children with CKD: a cross-sectional study. BMC Nephrol. 2017 Jun 28;18(1):204. doi: 10.1186/s12882-017-0623-5.

Lau L, Al-Ismaili Z, Harel-Sterling M, et al. Serum cystatin C for acute kidney injury evaluation in children treated with aminoglycosides. Pediatr Nephrol. 2017 Jan;32(1):163-171. doi: 10.1007/s00467-016-3450-1.

Marmarinos A, Garoufi A, Panagoulia A, et al. Cystatin-C levels in healthy children and adolescents: Influence of age, gender, body mass index and blood pressure. Clin Biochem. 2016 Jan;49(1-2):150-3. doi: 10.1016/j.clinbiochem.2015.10.012.

McCaffrey J, Coupes B, Chaloner C, Webb NJ, Barber R, Lennon R. Towards a biomarker panel for the assessment of AKI in children receiving intensive care. Pediatr Nephrol. 2015 Oct;30(10):1861-71. doi: 10.1007/s00467-015-3089-3.

Nakashima T, Inoue H, Fujiyoshi J, Matsumoto N. Longitudinal analysis of serum cystatin C for estimating the glomerular filtration rate in preterm infants. Pediatr Nephrol. 2016 Jun;31(6):983-9. doi: 10.1007/s00467-015-3309-x.

Nakhjavan-Shahraki B, Yousefifard M, Ataei N, et al. Accuracy of cystatin C in prediction of acute kidney injury in children; serum or urine levels: which one works better? A systematic review and meta-analysis. BMC Nephrol. 2017 Apr 3;18(1):120. doi: 10.1186/s12882-017-0539-0.

Pottel H, Delanaye P2, Schaeffner E, et al. Estimating glomerular filtration rate for the full age spectrum from serum creatinine and cystatin C. Nephrol Dial Transplant. 2017 Mar 1;32(3):497-507. doi: 10.1093/ndt/gfw425.

Roos JF, Doust J, Tett SE, Kirkpatrick CM. Diagnostic accuracy of cystatin C compared to serum creatinine for the estimation of renal dysfunction in adults and children—a meta-analysis. Clin Biochem. 2007 Mar;40(5-6):383-91. doi: 10.1016/j.clinbiochem.2006.10.026.

Sharma S, Denburg MR, Furth SL. The association between creatinine versus cystatin C-based eGFR and cardiovascular risk in children with chronic kidney disease using a modified PDAY risk score. Pediatr Nephrol. 2017 Aug;32(8):1457-1463. doi: 10.1007/s00467-017-3683-7.

Sherief LM, Youssef DM, Sherbiny HS, Abdelkhalek E, Talaat M, Khalifa NA. Screening of renal dysfunction among Burkitt lymphoma survivors by novel markers. Hematology. 2017 Jun;22(5):265-273. doi: 10.1080/10245332.2016.1259713.

Shlipak MG, Mattes MD, Peralta CA. Update on cystatin C: incorporation into clinical practice. Am J Kidney Dis. 2013 Sep;62(3):595-603. doi: 10.1053/j.ajkd.2013.03.027.

Treiber M, Pečovnik Balon B, Gorenjak M. A new serum cystatin C formula for estimating glomerular filtration rate in newborns. Pediatr Nephrol. 2015 Aug;30(8):1297-305. doi: 10.1007/s00467-014-3029-7.

Westland R, Abraham Y, Bökenkamp A, Stoffel-Wagner B, Schreuder MF, van Wijk JA. Precision of estimating equations for GFR in children with a solitary functioning kidney: the KIMONO study. Clin J Am Soc Nephrol. 2013 May;8(5):764-72. doi: 10.2215/CJN.07870812.

Copyright (c) 2020 S.V. Kushnirenko, Ye.M. Mordovets, N.A. Tihonenko, O.O. Markotenko

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.


© "Publishing House "Zaslavsky", 1997-2020


   Seo анализ сайта